Quality ManagementCommercialMedicare AdvantageJune 4, 2024

Antidepressant Medication Management (AMM)

HEDIS® is a widely used set of performance measures developed and maintained by the National Committee for Quality Assurance (NCQA). These measures are used to drive improvement efforts surrounding best practices.

The Antidepressant Medication Management measure looks at the percentage of members 18 years of age and older who were treated with antidepressant medication, had a diagnosis of major depression, and who remained on an antidepressant medication treatment May 1 of the year prior to the measurement year to April 30 of the measurement year. Two rates are reported:

  • Effective acute phase treatment: The percentage of members who remained on an antidepressant medication for at least 84 days (12 weeks).
  • Effective continuation phase treatment: The percentage of members who remained on an antidepressant medication for at least 180 days (six months).

Refer to attachment to view full details

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CRCM-060878-24-SRS60745, MULTI-BCBS-CRCM-046275-23-CPN45673

ATTACHMENTS: Antidepressant Medication Management (AMM) (pdf - 0.94mb)